Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–90. https://doi.org/10.1001/jamaneurol.2020.1127.

Article  PubMed  Google Scholar 

Raony Í, de Figueiredo CS, Pandolfo P, Giestal-de-Araujo E, Oliveira-Silva Bomfim P, Savino W. Psycho-neuroendocrine-immune interactions in COVID-19: potential impacts on mental health. Front Immunol. 2020;11:1170. https://doi.org/10.3389/fimmu.2020.01170.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sommer IE, Bakker PR. What can psychiatrists learn from SARS and MERS outbreaks? Lancet Psychiatry. 2020;7(7):565–6. https://doi.org/10.1016/s2215-0366(20)30219-4.

Article  PubMed  PubMed Central  Google Scholar 

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–27. https://doi.org/10.1016/s2215-0366(20)30203-0.

Article  PubMed  PubMed Central  Google Scholar 

Favas TT, Dev P, Chaurasia RN, Chakravarty K, Mishra R, Joshi D, et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020;41(12):3437–70. https://doi.org/10.1007/s10072-020-04801-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York city. Neurology. 2021;96(4):e575–e86. https://doi.org/10.1212/wnl.0000000000010979.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Javed A. Neurological associations of SARS-coV‑2 infection: a systematic review. CNS Neurol Disord Drug Targets. 2022;21(3):246–58. https://doi.org/10.2174/1871527320666210216121211.

Article  CAS  PubMed  Google Scholar 

Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, et al. A systematic review of neurological symptoms and complications of COVID-19. J Neurol. 2021;268(2):392–402. https://doi.org/10.1007/s00415-020-10067-3.

Article  CAS  PubMed  Google Scholar 

Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology. 2021;97(23):e2269–e81. https://doi.org/10.1212/wnl.0000000000012930.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rittmannsberger H, Barth M, Malik P, Yazdi K. Neuropsychiatric aspects of COVID-19—A narrative overview. Fortschr Neurol Psychiatr. 2022;90(3):108–20. https://doi.org/10.1055/a-1523-3850.

Article  PubMed  Google Scholar 

Rabady S, Altenberger J, Brose M, Denk-Linnert DM, Fertl E, Götzinger F, et al. Guideline S1: long COVID: diagnostics and treatment strategies. Wien Klin Wochenschr. 2021;133(Suppl 7):237–78. https://doi.org/10.1007/s00508-021-01974-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–15. https://doi.org/10.1038/s41591-021-01283-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ettman CK, Cohen GH, Abdalla SM, Sampson L, Trinquart L, Castrucci BC, et al. Persistent depressive symptoms during COVID-19: a national, population-representative, longitudinal study of U.S. adults. Lancet Reg Health Am. 2022;5:100091. https://doi.org/10.1016/j.lana.2021.100091.

Article  PubMed  Google Scholar 

Benfante A, Tesio V, Di Tella M, Romeo A, Castelli L. From the first to the second wave of COVID-19: anxiety, de-pressive, and post-traumatic stress symptoms in the Italian population. Int J Environ Res Public Health. 2022; https://doi.org/10.3390/ijerph19031239. 19(3).

Article  PubMed  PubMed Central  Google Scholar 

Robinson E, Sutin AR, Daly M, Jones A. A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in. J Affect Disord. 2020;2022(296):567–76. https://doi.org/10.1016/j.jad.2021.09.098.

Article  CAS  Google Scholar 

Rittmannsberger H, Barth M, Malik P, Malsiner-Walli G, Yazdi K. First episode psychotic disorders in the wake of the COVID-19 pandemic. A descriptive review of casereports. Acta Neuropsychiatr. 2022; https://doi.org/10.1017/neu.2022.11. 1–47.

Article  PubMed  Google Scholar 

Kumar M, Thakur AK. Neurological manifestations and comorbidity associated with COVID-19: an overview. Neurol Sci. 2020;41(12):3409–18. https://doi.org/10.1007/s10072-020-04823-6.

Article  PubMed  PubMed Central  Google Scholar 

Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Kanti Ray B. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2020; https://doi.org/10.1017/cjn.2020.173. 1–16.

Article  PubMed  PubMed Central  Google Scholar 

Steardo L Jr., Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatry. 2020;10(1):261. https://doi.org/10.1038/s41398-020-00949-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Sousa Moreira JL, Barbosa SMB, Vieira JG, Chaves NCB, Felix EBG, Feitosa PWG, et al. The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses. Prog Neuropsychopharmacol Biol Psychiatry. 2021; https://doi.org/10.1016/j.pnpbp.2020.110159. 106.

Article  PubMed  Google Scholar 

Ritchie K, Chan D. The emergence of cognitive COVID. World Psychiatry. 2021;20(1):52–3.

Article  PubMed  PubMed Central  Google Scholar 

Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, et al. Non-neuronal expression of SARS-CoV‑2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020; https://doi.org/10.1126/sciadv.abc5801. 6(31).

Article  PubMed  Google Scholar 

Bulfamante G, Chiumello D, Canevini MP, Priori A, Mazzanti M, Centanni S, et al. First ultrastructural autoptic findings of SARS-Cov‑2 in olfactory pathways and brainstem. Minerva Anestesiol. 2020;86(6):678–9. https://doi.org/10.23736/s0375-9393.20.14772-2.

Article  PubMed  Google Scholar 

Najt P, Richards HL, Fortune DG. Brain imaging in patients with COVID-19: a systematic review. Brain Behav Immun Health. 2021;16:100290. https://doi.org/10.1016/j.bbih.2021.100290.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV‑2 is associated with changes in brain structure in UK biobank. Nature. 2022; https://doi.org/10.1038/s41586-022-04569-5.

Article  PubMed  PubMed Central  Google Scholar 

Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin‑1 facilitates SARS-CoV‑2 cell entry and infectivity. Science. 2020;370(6518):856–60. https://doi.org/10.1126/science.abd2985.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gadanec LK, McSweeney KR, Qaradakhi T, Ali B, Zulli A, Apostolopoulos V. Can SARS-coV‑2 virus use multiple receptors to enter host cells? Int J Mol Sci. 2021; https://doi.org/10.3390/ijms22030992. 22(3).

Article  PubMed  PubMed Central  Google Scholar 

Maiese A, Manetti AC, Bosetti C, Del Duca F, La Russa R, Frati P, et al. SARS-coV‑2 and the brain: a review of the current knowledge on neuropathology in COVID-19. Brain Pathol. 2021; https://doi.org/10.1111/bpa.13013. e13013.

Article  PubMed  PubMed Central  Google Scholar 

Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Karteris E, et al. Neuropilin‑1 as a new potential SARS-coV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep. 2020;22(5):4221–6. https://doi.org/10.3892/mmr.2020.11510.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bodnar B, Patel K, Ho W, Luo JJ, Hu W. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. J Med Virol. 2020; https://doi.org/10.1002/jmv.26720.

Article  PubMed  PubMed Central  Google Scholar 

Orsini A, Corsi M, Santangelo A, Riva A, Peroni D, Foiadelli T, et al. Challenges and management of neurological and psychiatric manifestations in SARS-coV‑2 (COVID-19) patients. Neurol Sci. 2020;41(9):2353–66. https://doi.org/10.1007/s10072-020-04544-w.

Article  PubMed  PubMed Central  Google Scholar 

de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning. Alzheimers Dement. 2021; https://doi.org/10.1002/alz.12255.

Article  PubMed  PubMed Central